Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Clinical trial NCT03298048 · TERMINATED
Trial details
- NCT number
- NCT03298048
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2019-03-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.